Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound ...
Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise ...
This image provided by Eli Lilly on Wednesday, Nov. 8, 2023 shows packaging for their new drug Zepbound. (Eli Lilly via AP) Eli Lilly and Co. said Tuesday that “exceptionally strong demand ...
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its ...
Walmart raised its full-year forecast and reported better-than-expected quarterly results on Thursday, betting that easing ...
Drugmakers are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years. Starting this year, the number of new obesity ...
Shares of Inspire Medical Systems (NYSE:INSP) made a quick turnaround on Wednesday following a sharp decline as J.P. Morgan defended the stock after Eli Lilly (LLY) said its weight loss therapy ...
Frito Lay sales growth once gain drove PepsiCo's revenue gains despite CEO Ramon Laguarta seeing "higher than expected input cost inflation for the balance of 2022." PepsiCo said core earnings for ...
Along with its latest earnings print, Johnson & Johnson also said that it will increase its quarterly dividend payment to $1.24 U.S. a share, up 4.2% from $1.19 U.S. per share previously. This ...
May 2 (Reuters) - Becton Dickinson raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment and syringes.